Coalition of U.S. Women’s Health and HIV Advocates Call for Accelerated US Government Plan for Demonstrating Feasibility of PrEP for Women

March 4, 2013 - Atlanta, GA.  The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...